Clinical Trials Archives - The Global Ibogaine Therapy Alliance

18-Methoxycoronaridine: a potential new treatment for obesity in rats?

Authors: Olga D. Taraschenko, Heather Y. Rubbinaccio, Isabelle M. Maisonneuve, Stanley D. Glick
Published: Psychopharmacology
Date: 28 August 2008
Category:Medicine, Clinical Trials
Tags:18-mc, animal models, obesity
Comments:0

Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration

Authors: Stanley D. Glick, Elizabeth M. Sell, Isabelle M. Maisonneuve
Published: European Journal of Pharmacology
Date: December 2008
Category:Medicine, Clinical Trials
Tags:18-mc, methamphetamine, nicotine
Comments:0

18-Methoxycoronaridine blocks acquisition but enhances reinstatement of a cocaine place preference

Authors: Sarah E. McCallum, Stanley D. Glick
Published: Neuroscience Letters
Date: July 2009
Category:Medicine, Pharmacology, Clinical Trials
Tags:18-mc, addiction treatment, animal models, cocaine, place preference
Comments:0

Resistance of male Sprague–Dawley rats to sucrose-induced obesity: Effects of 18-methoxycoronaridine

Authors: Olga D. Taraschenko, Isabelle M. Maisonneuve, Stanley D. Glick
Published: Physiology & Behavior
Date: February 2011
Category:Medicine, Pharmacology, Clinical Trials
Tags:18-mc, animal models, obesity
Comments:0

Sex differences in high fat-induced obesity in rats: Effects of 18-methoxycoronaridine

Authors: unknown
Published: Physiology & Behavior
Date: July 2011
Category:Medicine, Pharmacology, Clinical Trials
Tags:18-mc, gender, nicotine, obesity
Comments:0

Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability

Authors: Paul Glue, Michelle Lockhart, Fred Lam, Noelyn Hung, Cheung-Tak Hung, Lawrence Friedhoff
Published: The Journal of Clinical Pharmacology
Date: December 2014
Category:Medicine, Clinical Trials
Tags:noribogaine, safety
Comments:0

Dependence studies of new compounds in the rhesus monkey and mouse (1991).

Authors: Aceto, M. D.; Bowman, E. R.; Harris, L. S. and May, E. L.
Published: NIDA Research Monograph
Date: 1992
Category:Medicine, Clinical Trials
Tags:animal models
Comments:0

Anti-addiction drug ibogaine on trial

Authors: Nancy Touchette
Published: Nat Med
Date: April 1995
Category:Medicine, Clinical Trials
Tags:animal models, efficacy, nida
Comments:0

Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats

Authors: Henry Sershen, Audrey Hashim, Abel Lajtha
Published: Neurochem Res
Date: November 1994
Category:Neurochemistry, Clinical Psychology, Medicine, Pharmacology, Clinical Trials
Tags:animal models, dopamine, serotonin
Comments:0

Ibogaine reduces preference for cocaine consumption in C57BL/6By mice

Authors: Henry Sershen, Audrey Hashim, Abel Lajtha
Published: Pharmacology Biochemistry and Behavior
Date: January 1994
Category:Neurochemistry, Medicine, Pharmacology, Clinical Trials
Tags:animal models, cocaine
Comments:0

The effect of ibogaine on sigma- and NMDA-receptor- mediated release of [3H]dopamine

Authors: Henry Sershen, Audrey Hashim, Abel Lajtha
Published: Brain Research Bulletin
Date: January 1996
Category:Neurochemistry, Clinical Psychology, Medicine, Pharmacology, Clinical Trials
Tags:dopamine
Comments:0

Effect of ibogaine on cocaine-induced efflux of [3H]dopamine and [3H]serotonin from mouse striatum

Authors: S Henry
Published: Pharmacology Biochemistry and Behavior
Date: April 1996
Category:Neurochemistry, Medicine, Pharmacology, Clinical Trials
Tags:animal models, cocaine, dopamine, serotonin
Comments:0

The effect of ibogaine on κ-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6BY mice

Authors: Henry Sershen, Audrey Hashim, Abel Lajtha
Published: Brain Research Bulletin
Date: January 1995
Category:Neurochemistry, Medicine, Pharmacology, Clinical Trials
Tags:animal models, dopamine
Comments:0

Serotonergic mediation of fenfluramine discriminative stimuli in Fawn-Hooded rats

Authors: Martin D. Schechte
Published: Life Sciences
Date: January 1997
Category:Neurochemistry, Medicine, Pharmacology, Clinical Trials
Tags:serotonin
Comments:0

Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity

Authors: Martin D. Schechter, Timothy L. Gordon
Published: European Journal of Pharmacology
Date: November 1993
Category:Medicine, Pharmacology, Clinical Trials
Comments:0

Clinical Trials

18-Methoxycoronaridine: a potential new treatment for obesity in rats?

Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration

18-Methoxycoronaridine blocks acquisition but enhances reinstatement of a cocaine place preference

Resistance of male Sprague–Dawley rats to sucrose-induced obesity: Effects of 18-methoxycoronaridine

Sex differences in high fat-induced obesity in rats: Effects of 18-methoxycoronaridine

Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability

Dependence studies of new compounds in the rhesus monkey and mouse (1991).

Anti-addiction drug ibogaine on trial

Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats

Ibogaine reduces preference for cocaine consumption in C57BL/6By mice

The effect of ibogaine on sigma- and NMDA-receptor- mediated release of [3H]dopamine

Effect of ibogaine on cocaine-induced efflux of [3H]dopamine and [3H]serotonin from mouse striatum

The effect of ibogaine on κ-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6BY mice

Serotonergic mediation of fenfluramine discriminative stimuli in Fawn-Hooded rats

Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity

2016 Conference

ACLS for Ibogaine Therapy

Clinical Guidelines

About Us

Stay Connected

Recently From Our Blog

Signup for our Newsletter